Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation

European Heart Journal

Volumn 29, Issue 9, 2008, Pages 1190-1197

  Dinanian, Sylvie ^a   Boixel, Christophe ^b,c   Juin, Christophe ^a   Hulot, Jean Sébastien ^b,c   Coulombe, Alain ^b,c   Rücker Martin, Catherine ^d   Bonnet, Nicolas ^e   Le Grand, Bruno ^f   Slama, Michel ^a   Mercadier, Jean Jacques ^b,g,h   Hatem, Stéphane N ^b,c  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CNRS   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h BICHAT HOSPITAL   (France)

Author keywords

Atrial dilatation; Atrial fibrillation; Atrial myocytes; Calcium current; Catecholamine

Indexed keywords

3 ISOBUTYL 1 METHYL XANTHINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOPRENALINE; PHOSPHODIESTERASE INHIBITOR;

ADULT; AGED; AORTA VALVE DISEASE; ARTICLE; CALCIUM CURRENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOWN REGULATION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART SURGERY; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MITRAL VALVE DISEASE; PRIORITY JOURNAL; SINUS RHYTHM;

ADRENERGIC BETA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CALCIUM CHANNELS, L-TYPE; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; RISK ASSESSMENT;

EID: 45349089551     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn140     Document Type: Article

References (36)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-473.
2. Aime-Sempe C, Folliguet T, Rucker-Martin C, Krajewska M, Krajewska S, Heimburger M, Aubier M, Mercadier JJ, Reed JC, Hatem SN. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 1999;34:1577-1586.
3. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-3163.
4. Boutjdir M, Le Heuzey JY, Lavergne T, Chauvaud S, Guize L, Carpentier A, Peronneau P. Inhomogeneity of cellular refractoriness in human atrium: factor of arrhythmia? Pacing Clin Electrophysiol 1986;9:1095-1100.
5. 2+ currents and human atrial fibrillation. Circ Res 1999;85:428-436.
6. Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The 'leading circle' concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 1977;41:9-18.
7. Nattel S, Li D, Yue L. Basic mechanisms of atrial fibrillation - very new insights into very old ideas. Annu Rev Physiol 2000;62:51-77.
8. Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, Nattel S. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 2000;101:2631-2638.
9. Le Grand BL, Hatem S, Deroubaix E, Couetil JP, Coraboeuf E. Depressed transient outward and calcium currents in dilated human atria. Cardiovasc Res 1994;28:548-556.
10. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D, Schoendube F, Hanrath P, Allessie MA. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 2001;103:691-698.
11. Schotten U, Haase H, Frechen D, Greiser M, Stellbrink C, Vazquez-Jimenez JF, Morano I, Allessie MA, Hanrath P. The L-type Ca2+-channel subunits alpha1C and beta2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation. J Mol Cell Cardiol 2003;35:437-443.
12. Gaspo R, Sun H, Fareh S, Levi M, Yue L, Allen BG, Hebert TE, Nattel S. Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation. Cardiovasc Res 1999;42:434-442.
13. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Leger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 2005;112:471-481.
14. Boixel C, Gonzalez W, Louedec L, Hatem SN. Mechanisms of L-type Ca(2+) current downregulation in rat atrial myocytes during heart failure. Circ Res 2001;89:607-613.
15. Deroubaix E, Folliguet T, Rucker-Martin C, Dinanian S, Boixel C, Validire P, Daniel P, Capderou A, Hatem SN. Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability. J Am Coll Cardiol 2004;44:1918-1926.
16. Boixel C, Dinanian S, Lang-Lazdunski L, Mercadier JJ, Hatem SN. Characterization of effects of endothelin-1 on the L-type Ca2+ current in human atrial myocytes. Am J Physiol Heart Circ Physiol 2001;281:H764- H773.
17. Bland JM, Altman DJ. Regression analysis. Lancet 1986;1:908-909.
18. Lai LP, Su MJ, Lin JL, Lin FY, Tsai CH, Chen YS, Huang SK, Tseng YZ, Lien WP. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 1999;33:1231-1237.
19. Ono K, Fozzard HA. Phosphorylation restores activity of L-type calcium channels after rundown in inside-out patches from rabbit cardiac cells. J Physiol 1992;454:673-688.
20. Bean BP, Nowycky MC, Tsien RW. Beta-adrenergic modulation of calcium channels in frog ventricular heart cells. Nature 1984;307:371-375.
21. Rivet-Bastide M, Vandecasteele G, Hatem S, Verde I, Benardeau A, Mercadier JJ, Fischmeister R. cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes. J Clin Invest 1997;99:2710-2718.
22. Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D. L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 2004;110:2651-2657.
23. Boyden PA, Tilley LP, Pham TD, Liu SK, Fenoglic JJ Jr, Wit AL. Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis. Am J Cardiol 1982;49:1896-1908.
24. Rossi A, Enriquez-Sarano M, Burnett JC Jr, Lerman A, Abel MD, Seward JB. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 2000;35:1256- 1262.
25. Zhou C, Ziegler C, Birder LA, Stewart AF, Levitan ES. Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA. Circ Res 2006;98:1040-1047.
26. Carnes CA, Janssen PM, Ruehr ML, Nakayama H, Nakayama T, Haase H, Bauer JA, Chung MK, Fearon IM, Gillinov AM, Hamlin RL, Van Wagoner DR. Atrial glutathione content, calcium current, and contractility. J Biol Chem 2007;282:28063-28073.
27. Hool LC, Arthur PG. Decreasing cellular hydrogen peroxide with catalase mimics the effects of hypoxia on the sensitivity of the L-type Ca2+ channel to beta-adrenergic receptor stimulation in cardiac myocytes. Circ Res 2002;91:601-609.
28. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 2003;108:1461-1468.
29. Verheule S, Wilson E, Everett TT, Shanbhag S, Golden C, Olgin J. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 2003;107:2615-2622.
30. Neuberger HR, Schotten U, Verheule S, Eijsbouts S, Blaauw Y, van Hunnik A, Allessie M. Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation 2005;111:30-37.
31. He Y, Xiao J, Yang Y, Zhou Q, Zhang Z, Pan Q, Liu Y, Chen Y. Stretch-induced alterations of human Kir2.1 channel currents. Biochem Biophys Res Commun 2006;351:462-467.
32. Otway R, Vandenberg JI, Guo G, Varghese A, Castro ML, Liu J, Zhao J, Bursill JA, Wyse KR, Crotty H, Baddeley O, Walker B, Kuchar D, Thorburn C, Fatkin D. Stretch-sensitive KCNQ1 mutation. A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol 2007;49:578-586.
33. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course andmechanisms. Circulation 1996;94:2968- 2974.
34. Workman AJ, Pau D, Redpath CJ, Marshall GE, Russell JA, Kane KA, Norrie J, Rankin AC. Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol 2006;17:1230-1238.
35. Rucker-Martin C, Milliez P, Tan S, Decrouy X, Recouvreur M, Vranckx R, Delcayre C, Renaud JF, Dunia I, Segretain D, Hatem SN. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res 2006;72:69-79.
36. Milliez P, Deangelis N, Rucker-Martin C, Leenhardt A, Vicaut E, Robidel E, Beaufils P, Delcayre C, Hatem SN. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J 2005;26:2193-2199.